4 Jan 2022 , 04:45 PM
Vanta Bioscience Ltd has informed that the Company has received an order of Rs1.18cr from Coromandel International Limited, India for carrying out various preclinical studies/toxicity studies on animals, agrochem studies and other studies.
This prestigious order also marks the official initiation of studies of the company’s Phys-chem vertical.
The said studies will be carried out by the Company from its state of art research facility at Gummidipundi, Chennai.
Vanta Bioscience ended at Rs129.85 apiece up by Rs11.15 or 9.39% on Sensex.
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
